NFKB1 and skin disorder: Human epidermal cells isolated from pathological skin, including patients with psoriasis and eczema, have shown that keratinocytes mediate inflammatory responses in skin disorders by the activation of NF-kB pathway that can be blocked by the expression of ABIN1 and A20, both inhibitors of NF-kB (Harirchian et al., 2019).